Benzimidazoles and benzothiazoles and uses thereof
AssigneeSynaptic Pharmaceutical Corporation
InventorsYoon T. Jeon, Charles Gluchowski
Life of this patent
Estimating the term…
Loading patent…
AssigneeSynaptic Pharmaceutical Corporation
InventorsYoon T. Jeon, Charles Gluchowski
Estimating the term…
This invention is directed to novel indole and benzothiazole compounds which are selective for cloned human alpha 2 receptors. This invention is also related to uses of these compounds for any indication where use of an alpha 2 agonist may be appropriate. Specifically, this includes use as analgesic, sedative and anaesthetic agents. In addition, this invention includes using such compounds for lowering intraocular pressure, presbyopia, treating migraine, hypertension, alcohol withdrawal, drug addiction, rheumatoid arthritis, ischemic pain, spasticity, diarrhea, nasal decongestion, urinary incontinence as well as for use as cognition enhancers and ocular vasoconstriction agents. The invention further provides a pharmaceutical composition comprising a therapeutically effective amount of the above-defined compounds and a pharmaceutically acceptable carrier.
A compound having the structure:
Dependencies are inferred from the claim text.